Tirzepatide (Injection)
Dual-action weight loss, once weekly
Compounded tirzepatide — a dual GIP/GLP-1 receptor agonist that has been studied extensively in clinical trials — prescribed online by licensed U.S. providers and delivered.
Overview
Compounded Tirzepatide injection is a once-weekly, dual-action weight-loss medication that works on two metabolic pathways at once. As a dual GIP and GLP-1 receptor agonist, it is prepared by a licensed U.S. compounding pharmacy after provider review.
How tirzepatide works
Dual GIP + GLP-1
Activates two incretin receptors for stronger, two-pathway appetite control.
Curbs appetite
Reduces hunger and cravings so eating less feels effortless.
Boosts fullness
Slows digestion and supports a healthy metabolic response.
At a glance — technical specifications
| Active ingredient | Tirzepatide |
|---|---|
| Drug class | Dual GIP & GLP-1 receptor agonist (twincretin) |
| What it does | Strong appetite control via two pathways; supports weight loss and blood-sugar control |
| How it works | Activates both GIP and GLP-1 receptors — reduces hunger, boosts fullness, improves metabolic response |
| Form | Subcutaneous injection |
| Administration | Once weekly; self-injected (abdomen, thigh, or upper arm) |
| Dose range | 2.5 mg → 15 mg (gradual titration) |
| Onset | Appetite changes often within the first few weeks; full effect builds over months |
| FDA status | Compounded — not FDA-approved. Prepared by a state-licensed U.S. compounding pharmacy after provider review |
| Prescription | Required — issued after licensed provider review |
| Storage | Refrigerate 36–46°F (2–8°C); protect from light |
Key benefits
The science
Average body-weight reduction at the 15 mg dose over 72 weeks in the SURMOUNT-1 trial — with up to ~22.9% at three years.* Results reflect clinical trial data for branded tirzepatide; compounded tirzepatide has not been separately evaluated by the FDA. Individual results vary.
FDA status
What's included with Mediclab
- Review by a licensed U.S. provider (all 50 states)
- Personalized treatment plan & dose titration
- Ongoing follow-up, tracking & refills
- Free, discreet shipping — HSA/FSA eligible
Safety & side effects
*SURMOUNT-1 clinical trial (tirzepatide). Compounded medications are prepared by a licensed pharmacy and are not FDA-approved or reviewed for safety, effectiveness, or quality. Prescription required; available only after provider review and approval. This information is for educational purposes only and is not medical advice. Individual results vary.
Free shipping
Easy return
Safe checkout